Pilot Studies on the Novel Hypothesis that TSPO (Peripheral Benzodiazepine Receptor) Is Involved in Benzodiazepine/“Z-Drug” Physical Dependence and/or Withdrawal
Benzodiazepines and other benzodiazepine receptor agonists, such as the “Z” drugs, are widely prescribed medications mainly used for treating anxiety and seizures, and for inducing sedation. Unfortunately, despite their popularity, benzodiazepine prescribing often exceeds recommendations and the consequences can be severe. On September 23, 2020, the United States FDA announced a new requirement for a Boxed Warning for benzodiazepines prescribing. Along with this announcement, the FDA stated that relevant information regarding the initiation, continuation, and discontinuation of benzodiazepines is lacking. Here, we describe initial pilot studies intended to investigate the questions 1) can animal models be developed that demonstrate benzodiazepine physical dependence and/or withdrawal symptoms, and 2) determine whether translocator protein (TSPO) plays a role in benzodiazepine dependence and/or withdrawal processes. The former was demonstrated, methodological limitations prevented the latter.
References
[1]
Milani, S.A., Raji, M.A., Chen, L. and Kuo, Y.-F. (2021) Trends in the Use of Benzodiazepines, Z-Hypnotics, and Serotonergic Drugs among Women and Men before and during the COVID-19 Pandemic. JAMA Network Open, 4, e2131012.
https://doi.org/10.1001/jamanetworkopen.2021.31012
[2]
Santo, L., Rui, P. and Ashman, J.J. (2020) Physician Office Visits at Which Benzodiazepines Were Prescribed: Findings from 2014-2016 National Ambulatory Medical Care Survey. National Health Statistics Reports, 137, 1-16.
[3]
Olfson, M., King, M. and Schoenbaum, M. Benzodiazepine Use in the United States. JAMA Psychiatry, 72, 136-142. https://doi.org/10.1001/jamapsychiatry.2014.1763
[4]
Agarwal, S.D. and Landon, B.E. (2019) Patterns in Outpatient Benzodiazepine Prescribing in the United States. JAMA Network Open, 2, e187399.
https://doi.org/10.1001/jamanetworkopen.2018.7399
[5]
Guina, J. and Merrill, B. (2018) Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives. Journal of Clinical Medicine, 7, Article 17. https://doi.org/10.3390/jcm7020017
[6]
López-Munoz, F., álamo, C. and García-García, P. (2011) The Discovery of Chlordiazepoxide and The Clinical Introduction of Benzodiazepines: Half a Century of Anxiolytic Drugs. Journal of Anxiety Disorders, 25, 554-562.
https://doi.org/10.1016/j.janxdis.2011.01.002
[7]
Wick, J.Y. (2013) The History of Benzodiazepines. Consultant Pharmacist, 28, 538-548. https://doi.org/10.4140/TCP.n.2013.538
[8]
Griffin 3rd, C.E., Kaye, A.M., Bueno, F.R. and Kaye, A.D. (2013) Benzodiazepine Pharmacology and Central Nervous System-Mediated Effects. Ochsner Journal, 13, 214-223.
[9]
Schmitz, A. (2016) Benzodiazepine Use, Misuse, and Abuse: A Review. The Mental Health Clinician, 6, 120-126. https://doi.org/10.9740/mhc.2016.05.120
[10]
Longo, L.P. and Johnson, B. (2000) Addiction: Part I. Benzodiazepines-Side Effects, Abuse Risk and Alternatives. American Family Physician, 61, 2121-2128.
[11]
Ashton, H. (1991) Protracted Withdrawal Syndromes from Benzodiazepines. Journal of Substance Abuse Treatment, 8, 19-28.
https://doi.org/10.1016/0740-5472(91)90023-4
[12]
Volkow, N.D., et al. (2010) Addiction: Decreased Reward Sensitivity and Increased Expectation Sensitivity Conspire to Overwhelm the Brain's Control Circuit. Bioessays, 32, 748-755. https://doi.org/10.1002/bies.201000042
[13]
White, N.M. (2011) Chapter 3. Reward: What Is It? How Can It Be Inferred from Behavior? In: Gottfried, J.A., Ed., Neurobiology of Sensation and Reward, CRC Press/Taylor & Francis.
[14]
McKendrick, G. and Graziane, N.M. (2020) Drug-Induced Conditioned Place Preference and Its Practical Use in Substance Use Disorder Research. Frontiers In Behavioral Neuroscience, 14, Article ID: 582147.
https://doi.org/10.3389/fnbeh.2020.582147
[15]
Petursson, H. and Lader, M.H. (1981) Withdrawal from Long-Term Benzodiazepine Treatment. British Medical Journal (Clinical Research Ed.), 283, 643-645.
https://doi.org/10.1136/bmj.283.6292.643
[16]
de las Cuevas, C., Sanz, E.J., de la Fuente, J.A., Padilla, J. and Berenguer, J.C. (2000) The Severity of Dependence Scale (SDS) as Screening Test for Benzodiazepine Dependence: SDS Validation Study. Addiction, 95, 245-250.
https://doi.org/10.1046/j.1360-0443.2000.95224511.x
[17]
Higgitt, A., Fonagy, P., Toone, B. and Shine, P. (1990) The Prolonged Benzodiazepine Withdrawal Syndrome: Anxiety or Hysteria? Acta Psychiatrica Scandinavica, 82, 165-168. https://doi.org/10.1111/j.1600-0447.1990.tb01375.x
[18]
Schweizer, E. and Rickels, K. (1998) Benzodiazepine Dependence and Withdrawal: A Review of the Syndrome and Its Clinical Management. Acta Psychiatrica Scandinavica. Supplementum, 393, 95-101.
https://doi.org/10.1111/j.1600-0447.1998.tb05973.x
[19]
Papadopoulos, V., et al. (2006) Translocator Protein (18kDa): New Nomenclature for the Peripheral-Type Benzodiazepine Receptor Based on Its Structure and Molecular Function. Trends in Pharmacological Sciences, 27, 402-409.
https://doi.org/10.1016/j.tips.2006.06.005
[20]
Gavish, M., et al. (1999) Enigma of the Peripheral Benzodiazepine Receptor. Pharmacological Reviews, 51, 629-650.
[21]
Chaplan, S.R., Bach, F.W., Pogrel, J.W., Chung, J.M. and Yaksh, T.L. (1994) Quantitative Assessment of Tactile Allodynia in the Rat Paw. Journal of Neuroscience Methods, 53, 55-63. https://doi.org/10.1016/0165-0270(94)90144-9
[22]
Moffett, C., et al. (2021) The FDA Mandate to Reassess Benzodiazepines: Alprazolam Induces a Positive Conditioned Place-Preference in Male Rats. Journal of Biosciences and Medicines, 9, 1-8. ttps://doi.org/10.4236/jbm.2021.93001
[23]
Moffett, C., et al. (2021) Test of the Popular Benzodiazepine Alprazolam in a Positive Conditioned Place-Preference Model in Female Rats. Journal of Pharmacy and Pharmacology, 12, 100-108. https://doi.org/10.4236/pp.2021.125010
[24]
Raffa, R. and Pergolizzi, J. (2019) Commentary: Benzodiazepine (BZD) and Related bzd-Receptor Agonists: Basic Science Reasons to Limit to Four Weeks or Less. Journal of Pharmacy and Pharmacology, 10, 357-364.
https://doi.org/10.4236/pp.2019.108029
[25]
Peppin, J.F., Pergolizzi, J.V., Raffa, R.B. and Wright, S.L. (2020) The Benzodiazepines Crisis: The Ramifications of an Over-Used Drug Class. Oxford University Press, Oxford. https://doi.org/10.1093/med/9780197517277.001.0001
